Complementing Mutations in Core Binding Factor Leukemias: From Mouse Models to Clinical Applications

Oncogene - United Kingdom
doi 10.1038/onc.2008.196
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Clinical Mutatome of Core Binding Factor Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

BRAF Mutations in Acute Leukemias

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Immunophenotyping of Acute Leukemias – From Biology to Clinical Application

2016English

Venous Thrombosis and Cancer: From Mouse Models to Clinical Trials

Journal of Thrombosis and Haemostasis
MedicineHematology
2015English

Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications

Neurotherapeutics
NeurologyPharmacology
2015English

Immunofluorescent Studies of Viral Antigens in Mouse Leukemias

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1966English

Survival Is Poorer in Patients With Secondary Core Binding Factor Acute Myelogenous Leukemia Compared With De Novo Core Binding Factor Leukemia.

Blood
BiochemistryImmunologyCell BiologyHematology
2007English

Activating FLT3 Mutations in CD117/KIT+ T-Cell Acute Lymphoblastic Leukemias

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Absence of H2AX Gene Mutations in B-Cell Leukemias and Lymphomas

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy